AMARIN CORP PLC\UK Repayments of Financial Services Obligations (Deprecated 2016-01-31)
AMARIN CORP PLC\UK (AMRN) reported Repayments of Financial Services Obligations (Deprecated 2016-01-31) of $2.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfFinancialServicesObligations · last filed 2012-02-29
- AMARIN CORP PLC\UK repayments of financial services obligations (deprecated 2016-01-31) for fiscal 2011 was $2.00K, a 83.33% decline from fiscal 2010.
- AMARIN CORP PLC\UK repayments of financial services obligations (deprecated 2016-01-31) for fiscal 2010 was $12.00K, a 0.00% change from fiscal 2009.
- AMARIN CORP PLC\UK repayments of financial services obligations (deprecated 2016-01-31) for fiscal 2009 was $12.00K.
| Period end | Repayments of Financial Services Obligations (Deprecated 2016-01-31) 12 month |
|---|---|
| 2011-12-31 | $2.00K 10-K · filed 2012-02-29 |
| 2010-12-31 | $12.00K 10-K · filed 2012-02-29 |
| 2009-12-31 | $12.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |